Connect with us

Hi, what are you looking for?


Cavs forward suspended 25 games for violating NBA Anti-Drug Program

The Cleveland Cavaliers will be without Tristan Thompson for roughly the next two months.

Thompson has been suspended 25 games by the NBA for violating the league’s NBA/NBPA Anti-Drug Program. He tested positive for ibutamoren and SARM LGD-4033, both of which are considered performance enhancers, according to a league statement.

Thompson’s suspension will begin with Wednesday’s game against the Milwaukee Bucks. He’ll be eligible to return from the suspension for the Cavs’ March 16 game against the Houston Rockets.

This past offseason, Thompson signed a one-year deal with the Cavs worth just north of $3.1 million. Off the bench, he’s averaged 3.8 points and 3.9 rebounds in 12.4 minutes per game.

What is ibutamoren? Tristan Thompson suspended for violation

Ibutamoren is a potent, orally-active drug that helps to increase growth hormone production. It’s often used as a regenerative medicine for adults struggling with age-related medical conditions. It’s noted by the World Anti-Doping Agency as a dangerous chemical substance.

What is SARM LGD-4033?

Ryan Lewis can be reached at Follow him on X at @ByRyanLewis.

This post appeared first on USA TODAY

    You May Also Like


    The 2023 NTT IndyCar season kicks off this weekend in Florida following an offseason of change in the paddock. Eight full-time IndyCar drivers —...


    Four division titles — AFC East, NFC East, AFC South and NFC South — will be decided in NFL Week 18. In all, 11...


    Kalen DeBoer says Nick Saban will retain ‘100% access’ to Alabama football program, with DeBoer’s blessingNick Saban wasn’t over Kalen DeBoer’s shoulder at introductory...


    The Kansas City Chiefs and Miami Dolphins have weathered various storms throughout the regular season, from injuries to inconsistent play, but on Saturday, both...

    Disclaimer:, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

    Copyright © 2023 | All Rights Reserved